{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:18:35Z","timestamp":1777864715021,"version":"3.51.4"},"reference-count":10,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J R Soc Med"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:p>Tamoxifen exposure is a recognised risk for primary endometrial cancer. This case serves as a reminder to meticulously check the past medical history and inform patients of the risk-benefit of treatment as part of a shared-decision making process.<\/jats:p>","DOI":"10.1177\/0141076820961087","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T10:06:48Z","timestamp":1602497208000},"page":"454-456","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Recurrence of endometrial cancer in a hysterectomised patient treated with tamoxifen for breast cancer: a case report"],"prefix":"10.1177","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1165-2197","authenticated-orcid":false,"given":"James","family":"Woolas","sequence":"first","affiliation":[{"name":"Peninsula School of Medicine and Dentistry, Plymouth University, Plymouth PL6 8BU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Davis","sequence":"additional","affiliation":[{"name":"Torbay and South Devon Foundation NHS Trust, Torquay TQ2 7AA, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siavash","family":"Rahimi","sequence":"additional","affiliation":[{"name":"Frontier Pathology-Histopathology, Brighton and Sussex University Hospitals NHS Trust, Brighton BN2 5BE, UK"},{"name":"School of Pharmacy, University of Portsmouth, Portsmouth PO1 2DT, UK"},{"name":"School of Biomedical Sciences, University of Portsmouth, Portsmouth PO1 2DT, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.10.010"},{"key":"e_1_3_4_3_2","doi-asserted-by":"crossref","unstructured":"Kurman R Kamunski P and Norris H. The behaviour of endometrial hyperplasia. A long term study of \u201cuntreated\u201d hyperplasia in 170 patients. Cancer 1985; 56(2). doi: 10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X.","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X"},{"key":"e_1_3_4_4_2","doi-asserted-by":"crossref","unstructured":"Jones M et\u00a0al. Endometrial cancer survival after breast cancer in relation to Tamoxifen treatment: pooled results from three countries. Breast Cancer Res 2012; 14(91). doi:10.1186\/bcr3206.","DOI":"10.1186\/bcr3206"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.7150\/jca.13141"},{"key":"e_1_3_4_6_2","unstructured":"National Institute for Health and Care Excellence (NICE). Familial Breast Cancer: Classification Care and Managing Breast Cancer and Related Risks in People with a Family History of Breast Cancer [CG164]. See https:\/\/www.nice.org.uk\/guidance\/cg164\/chapter\/Recommendations#ftn.footnote_6 (last checked 8 September 2020)."},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.4103\/2278-330X.105867"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2014.2362"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.06.042"},{"key":"e_1_3_4_10_2","unstructured":"Takahashi A. Late Recurrence of Endometrial Cancer Observed in Only 1% of Women. European Society of Oncology Asia Cancer Symposium 25 February 2015. See https:\/\/journals.lww.com\/oncology-times\/fulltext\/2016\/02250\/late_recurrence_of_endometrial_cancer_observed_in.13.aspx (last checked 8 September 2020)."},{"issue":"3","key":"e_1_3_4_11_2","first-page":"179","article-title":"Factors predicting recurrent endometrial cancer","volume":"5","author":"Huijgens A","year":"2013","unstructured":"Huijgens A, Mertens H. Factors predicting recurrent endometrial cancer. Facts Views Vision Obstetr Gynaecol Reproduct Health 2013; 5(3): 179\u2013186.","journal-title":"Facts Views Vision Obstetr Gynaecol Reproduct Health"}],"container-title":["Journal of the Royal Society of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0141076820961087","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0141076820961087","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0141076820961087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:47:12Z","timestamp":1777528032000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0141076820961087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1177\/0141076820961087"],"URL":"https:\/\/doi.org\/10.1177\/0141076820961087","relation":{},"ISSN":["0141-0768","1758-1095"],"issn-type":[{"value":"0141-0768","type":"print"},{"value":"1758-1095","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]}}}